Healthcare -
Biotechnology - NASDAQ - US
$ 31.49
-0.317 %
$ 14 B
Market Cap
12.4
P/E
RPRX - ACCOUNTS PAYABLE
Accounts Payable RPRX - Royalty Pharma plc
15.2 M
LAST VALUE
64.27%
2 YEAR CAGR
27.64%
5 YEAR CAGR
0.00%
10 YEAR CAGR